QIASCOUT
DEAD

Serial Number

79204529

Owner

QIAGEN GMBH

Attorney

Keith A. Weltsch

Filing Date

Nov 28, 2016

Add to watchlist:

No watchlists yet
View on USPTO

QIASCOUT Trademark

Serial Number: 79204529 • Registration: 5388867

QIASCOUT is a trademark filed by QIAGEN GMBH on November 28, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

November 28, 2016

Registration Date

January 30, 2018

Published for Opposition

November 14, 2017

Cancellation Date

August 16, 2024

Goods & Services

Scientific apparatuses, instruments and devices, as well as their replacement parts and components included in this class for culturing, sorting, separation, manipulation and isolation of cells; laboratory apparatus and instruments in particular plates in the nature of well plates, spot plates, multi-well plates that can be used in biochemical and chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use, plates for seeding, culturing, sorting collecting, separating, and isolating cells for scientific and research purposes magnetic collection plates, used in the area of cell culturing and cell analysis, platforms in the nature of shaking platforms, rocker platforms, platforms for use in a laboratory device for automated single cell isolation for scientific and research purposes, drug-screening platforms, namely, for use in a laboratory device for automated single cell isolation for scientific and research purposes, tubes in the nature of test tubes, reaction tubes, glass tubes, plastic tubes, Polymerase chain reaction (PCR) tubes, cell-culture dishes, arrays, namely, microarrays, microraft arrays for seeding, culturing, sorting collecting, separating, isolating cells for scientific and research purposes, microwell arrays, magnetic multi-well plates in an array format, vessels, namely, cell culture vessels, reaction tubes, Polymerase chain reaction (PCR) tubes, needles, namely, needles for use in culturing, sorting, collection, separation and isolation and analysis of cells for scientific and research purposes, wands, namely, magnetic wands for use in culturing, sorting, collection, separation, isolation and analysis of cells for scientific and research purposes, for use in scientific and medical research; scientific apparatuses and instruments, in particular microscopes, x-ray microscopes, fluorescence microscopes, confocal microscopes, cameras, bright-field scanners and microscopes, magnetic microdevices, in particular, multi-well plates in an array format, for culturing, sorting, collection, separation and isolation of cells for scientific and research purposes; software for culturing, sorting collecting, separating, and isolation cells for scientific and research purposes in the area of cell analysis

Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, in particular diagnostics for sample preparation, modification and manipulation and isolation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations, in particular reagents, enzymes and buffer solutions for sample preparation, modification and manipulation and isolation of cells for medical and veterinary diagnostic purposes; chemical, biochemical and biotechnological preparations, in particular reagents, enzymes and buffer solutions for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing for medical and veterinary diagnostic purposes; kits containing preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, chemical and biochemical substances, reagents, chemical and biochemical solutions, chemical and biochemical suspensions, and diagnostic preparations for scientific and research purposes; non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use, for sample preparation, isolation, separation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals and reagents for sample preparation, isolation, separation, modification and manipulation of cells for scientific and research purposes; kits for scientific and research purposes comprising chemicals and reagents for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Aug 8, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 17, 2025 INTS
INVALIDATION PROCESSED
Jul 17, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 16, 2025 INTR
CANCELLED SECTION 71
Aug 16, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 30, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 15, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 3, 2018 FICS
FINAL DISPOSITION PROCESSED
May 3, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2017 NONP
ASSIGNED TO LIE
Oct 9, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 27, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 27, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 27, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 27, 2017 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 23, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 23, 2017 REAP
REFUSAL PROCESSED BY IB
May 13, 2017 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 21, 2017 RFCS
REFUSAL PROCESSED BY MPU
Apr 21, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 19, 2017 RFCR
NON-FINAL ACTION WRITTEN
Apr 18, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 14, 2017 MAFR
ASSIGNED TO EXAMINER
Apr 10, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 6, 2017 REPR